Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01376271

Enrollment

600

Registered

2011-06-20

Start date

2010-01-31

Completion date

2013-09-30

Last updated

2014-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Phobia

Brief summary

The study is designed to evaluate the safety and efficacy of paroxetine on the long-term use in Japanese Social Anxiety Disorder (SAD) subjects.

Interventions

DRUGParoxetine

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Subjects who are diagnosed as having SAD * Subjects who are expected to use paroxetine tablets for the first time

Exclusion criteria

* Subjects taking pimozide * Subjects taking monoamine oxidase (MAO) inhibitor or within two weeks after discontinuation of MAO inhibitor * Subjects with hypersensitivity to paroxetine

Design outcomes

Primary

Measure	Time frame
The number of adverse events in Japanese subjects with social anxiety disorder treated with paroxetine tablets	1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026